Budget Amount *help |
¥3,640,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥540,000)
Fiscal Year 2009: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2008: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2007: ¥1,300,000 (Direct Cost: ¥1,300,000)
|
Research Abstract |
To generate gene therapy vector for ataxia telangiectasia (AT), we constructed novel human artificial chromosome (HAC) containing ATM gene, which is mutated in ataxia telangiectasia (AT) patients. The ATM-HAC were transferred into ATM-deficient cell line derived from a AT patient. The ATM-deficient phenotypes of gene regulation and radiation sensitivity were complemented by introducing the ATM-HAC. Furthermore, the ATM-HAC was stably maintained in the cell lines. Thus, the ATM-HAC vector will be useful for gene therapy of AT.
|